Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | Calcium phosphate only product in oral dose form | false | Inferred relationship | Some | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | Product containing only durapatite (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Durapatite | true | Inferred relationship | Some | 1 | |
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Durapatite | true | Inferred relationship | Some | 1 | |
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | Durapatite only product in oral dose form | true | Inferred relationship | Some | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | Durapatite-containing product | false | Inferred relationship | Some | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | a pour principe actif (attribut) | Mineral supplement (substance) | false | Inferred relationship | Some | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | a pour principe actif (attribut) | Nutrient supplementation (substance) | false | Inferred relationship | Some | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | a une forme pharmaceutique (attribut) | comprimé | false | Inferred relationship | Some | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | a pour principe actif (attribut) | agent pour l'appareil génito-urinaire | false | Inferred relationship | Some | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | a pour principe actif (attribut) | Durapatite | false | Inferred relationship | Some | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | a pour principe actif (attribut) | Nutritional supplement (substance) | false | Inferred relationship | Some | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | a pour principe actif (attribut) | Hydroxyapatite (substance) | false | Inferred relationship | Some | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | a une forme pharmaceutique (attribut) | Oral tablet | true | Inferred relationship | Some | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | Product manufactured as oral dose form (product) | false | Inferred relationship | Some | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | a pour principe actif (attribut) | Hydroxyapatite (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Hydroxyapatite (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value (attribute) | 830 (qualifier value) | false | Inferred relationship | Some | 1 | |
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 1 | |
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Some | 1 | |
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Hydroxyapatite (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | Durapatite-containing product in oral dose form | false | Inferred relationship | Some | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Count of base of active ingredient | un | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR